MODIFICATION
A -- Valproic Acid for the Treatment of Significant Hemorrhage
- Notice Date
- 10/6/2020 10:41:34 AM
- Notice Type
- Justification
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- W4PZ USA MED RSCH ACQUIS ACT FORT DETRICK MD 21702-5014 USA
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH20VPA
- Archive Date
- 11/05/2020
- Point of Contact
- Jeanette Wolfe
- E-Mail Address
-
jeanette.m.wolfe.civ@mail.mil
(jeanette.m.wolfe.civ@mail.mil)
- Award Number
- W81XWH20C0122
- Award Date
- 09/24/2020
- Description
- Sole source contract for the research and development to procure services of an investigational new drug (IND) sponsor for the performance of good clinical practice (GCP) compliant clinical trials leading to a new indication for valproic acid (VPA) for the treatment of patients with significant hemorrhage.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/196542efdf2641c5a0b40a03b8d27488/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN05819403-F 20201008/201006230137 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |